Predictors of Successful Cardioversion with Vernakalant in Patients with Recent-Onset Atrial Fibrillation

Author： Mochalina Natalia   Juhlin Tord   Öhlin Bertil   Carlson Jonas   Holmqvist Fredrik   Platonov Pyotr G.  

Publisher： Blackwell Publishing

E-ISSN： 1542-474X|20|2|140-147

ISSN： 1082-720X

Source： Annals of Noninvasive Electrocardiology, Vol.20, Iss.2, 2015-03, pp. : 140-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Intravenous Vernakalant in Recent-Onset Atrial Fibrillation†

By Duggan Sean T.   Scott Lesley J.  

Drugs & Aging, Vol. 28, Iss. 6, 2011-06 ,pp. : 501-504

Adis International

Access to resources Recommend Favorite

Intravenous vernakalant: a guide to its use in recent-onset atrial fibrillation

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 8, 2011-08 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite

Intravenous Vernakalant: A Review of its Use in the Management of Recent-Onset Atrial Fibrillation

By Duggan Sean T.   Scott Lesley J.  

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 237-252

Adis International

Access to resources Recommend Favorite

The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and Flutter: Focus on Ibutilide

By Obel O.A.   Camm A.J.  

Drugs & Aging, Vol. 12, Iss. 6, 1998-06 ,pp. : 461-476

Adis International

Access to resources Recommend Favorite

Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity

By Blomström-Lundqvist Carina   Blomström Per  

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite